Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tolerability, Safety and Efficacy of Vortioxetine for Treatment od Depression in Parkinson's Disease: a 16 Week Open Label Study

NCT04301492 is registered in ClinicalTrials.gov with IRCCS San Raffaele Roma as lead sponsor.

NCT NCT04301492
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04301492 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tolerability, Safety and Efficacy of Vortioxetine for Treatment od Depression in Parkinson's Disease: a 16 Week Open Label Study
Lead sponsor
IRCCS San Raffaele Roma
Phase
Phase 4
Overall status
Unknown status
Start date
November 20, 2019
Completion date
July 30, 2023
Enrollment
20 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

depression